| Fredun Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 539730 |
NSE Symbol : - |
P/E(TTM) : 28.48 |
|
ISIN Demat : INE194R01017 |
Div & Yield% : 0.04 |
EPS(TTM) : 61.21 |
|
Book Value(₹) : 333.71 |
Market Cap(₹Cr) : 823.17 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 143.59 | 119.40 | 165.44 | 101.84 | 106.89 | 77.54 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 143.59 | 119.40 | 165.44 | 101.84 | 106.89 | 77.54 |
| Other Operating Income | 1.71 | 0.45 | 1.97 | 0.86 | 0.46 | 1.28 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 145.29 | 119.86 | 167.41 | 102.70 | 107.35 | 78.81 |
| Total Expenditure | 122.96 | 102.86 | 149.97 | 89.47 | 93.40 | 68.33 |
| PBIDT | 22.34 | 16.99 | 17.44 | 13.23 | 13.95 | 10.48 |
| Interest | 7.73 | 6.53 | 8.15 | 5.00 | 5.31 | 3.91 |
| PBDT | 14.60 | 10.46 | 9.29 | 8.22 | 8.64 | 6.57 |
| Depreciation | 1.60 | 1.42 | 1.25 | 1.09 | 1.06 | 1.05 |
| Tax | 3.27 | 2.27 | 0.97 | 1.80 | 3.30 | 1.39 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 9.73 | 6.77 | 7.07 | 5.33 | 4.27 | 4.13 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 9.73 | 6.77 | 7.07 | 5.33 | 4.27 | 4.13 |
| EPS (Unit Curr.) | 20.61 | 14.33 | 14.98 | 11.29 | 9.05 | 8.79 |
| EPS (Adj) (Unit Curr.) | 20.61 | 14.33 | 14.98 | 11.29 | 9.05 | 8.79 |
| Calculated EPS (Unit Curr.) | 20.61 | 14.33 | 14.98 | 11.29 | 9.05 | 8.79 |
| Calculated EPS (Adj) (Unit Curr.) | 20.61 | 14.33 | 14.98 | 11.29 | 9.05 | 8.79 |
| Calculated EPS (Ann.) (Unit Curr.) | 82.45 | 57.32 | 59.91 | 45.18 | 36.20 | 35.15 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 82.45 | 57.32 | 59.91 | 45.18 | 36.20 | 35.15 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 4.72 | 4.72 | 4.72 | 4.72 | 4.72 | 4.70 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 2,411,277.00 | 2,411,277.00 | 2,411,277.00 | 2,411,277.00 | 2,411,277.00 | 2,388,777.00 |
| Public Shareholding (% in Equity) | 51.07 | 51.07 | 51.07 | 51.07 | 50.84 | 50.83 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 2,310,385.00 | 2,310,385.00 | 2,310,385.00 | 2,310,385.00 | 2,310,385.00 | 2,310,385.00 |
| Non Encumbered - % in Total Promoters Holding | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Non Encumbered - % in Total Equity | 48.93 | 48.93 | 48.93 | 48.93 | 49.16 | 49.17 |
| PBIDTM(%) | 15.56 | 14.23 | 10.54 | 12.99 | 13.05 | 13.52 |
| PBDTM(%) | 10.17 | 8.76 | 5.62 | 8.07 | 8.08 | 8.47 |
| PATM(%) | 6.78 | 5.67 | 4.27 | 5.23 | 3.99 | 5.33 |